Team Inc
Change company Symbol lookup
Select an option...
TISI Team Inc
PRTK Paratek Pharmaceuticals Inc
KIRY Kiewit Royalty Trust
OCAXW OCA Acquisition Equity Warrant Exp 14 Jan 2026 *W EXP 01/31/2028
ABBV Abbvie Inc
IIIN Insteel Industries Inc
KO Coca-Cola Co
MOD Modine Manufacturing Co
WABC Westamerica Bancorp
LUV Southwest Airlines Co
Go

Industrials : Commercial Services & Supplies | Small Cap Value
Company profile

Team, Inc. is a provider of integrated, digitally-enabled asset performance assurance and optimization solutions. The Company’s segments include Inspection and Heat Treating (IHT), Mechanical Services (MS) and Quest Integrity. IHT segments provides conventional and advanced non-destructive testing services primarily for the process, pipeline and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. MS provides solutions designed to serve both the operational (onstream) and off-line states of their assets. Its onstream service offers a range of standard to custom-engineered leak repair and composite solutions, emissions control and compliance, hot tapping and line stopping and on-line valve insertion solutions. Quest Integrity provides integrity and reliability management solutions for the process, pipeline and power sectors.

Closing Price
$1.34
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
517,378
0

Longeveron to Release Third Quarter 2021 Financial Results and Hold Conference Call on November 12, 2021

8:30 am ET November 8, 2021 (Globe Newswire) Print

Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced that the Company will release its third quarter 2021 financial results on Friday, November 12, 2021 before the open of US markets. Management will host a conference call on the same day at 8:30 a.m. ET.

The conference call will be available via telephone by dialing toll free 1-844-200-6205 for U.S. callers; 1-646-904-5544 for local callers; or +1 929-526-1599 for international callers and using entry code 397367. An audio replay of the of the call will be available through November 18, 2021.

A webcast of the call may be accessed from the "Events & Presentations" page on the Longeveron website at https://investors.longeveron.com/events-and-presentations/default.aspx, where you may also pre-register for the event. The recorded webcast will remain accessible for one year through November 12, 2022.

About Longeveron Inc.

Longeveron is a clinical stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B(TM) cell-based therapy product ("Lomecel-B"), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young, healthy adult donors. Longeveron believes that by using the same cells that promote tissue repair, organ maintenance, and immune system function, it can develop safe and effective therapies for some of the most difficult disorders associated with the aging process and other medical disorders. Longeveron is currently sponsoring Phase 1 and 2 clinical trials in the following indications: Aging Frailty, Alzheimer's disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). The Company's mission is to advance Lomecel-B and other cell-based product candidates into pivotal Phase 3 trials, with the goal of achieving regulatory approvals, subsequent commercialization and broad use by the healthcare community. Additional information about the Company is available at www.longeveron.com.

Contact:

Brendan Payne

Stern Investor Relations

Tel: (212) 362-1200

Email: Brendan.payne@sternir.com

Source: Longeveron Inc

Source: LGVN

https://ml.globenewswire.com/media/0d64726b-0028-42d8-902f-1e67d243019c/small/longeverson-jpg.jpg

https://ml.globenewswire.com/media/0d64726b-0028-42d8-902f-1e67d243019c/small/longeverson-jpg.jpg

comtex tracking

COMTEX_396512255/2010/2021-11-08T08:30:01

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.